Dragos Plesca
Impact in
-
- Cancer-related Molecular Pathways
- CAR-T cell therapy research
-
- MicroRNA in disease regulation
Papers in
- Oncology 10
- Cancer-related Molecular Pathways 5
- Neutropenia and Cancer Infections 3
-
- Cell death mechanisms and regulation 5
- DNA Repair Mechanisms 4
- Co-authors
- Alexandru Almasan (8 shared papers)Suparna Mazumder (7 shared papers)Michael Kinter (1 shared paper)Zahra Mahmoudjafari (1 shared paper)Kathryn A. Culos (1 shared paper)Katie S. Gatwood (1 shared paper)Meredith E. Crosby (1 shared paper)Damodar Gupta (1 shared paper)
- Journals
- Blood (3 papers)Cell Cycle (2 papers)Biology of Blood and Marrow Transplantation (2 papers)Clinical Pharmacology & Therapeutics (1 paper)American Journal of Health-System Pharmacy (1 paper)
- Partner nations
- United StatesAustralia
In The Last Decade
Dragos Plesca
18 papers receiving 815 citations
Peers
Comparison fields: 5 of 98
- Oncology 194
- Cancer Research 91
- Transplantation 14
- Molecular Biology 384
- Pharmacology 47
Countries citing papers authored by Dragos Plesca
This map shows the geographic impact of Dragos Plesca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dragos Plesca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dragos Plesca more than expected).
Fields of papers citing papers by Dragos Plesca
This network shows the impact of papers produced by Dragos Plesca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dragos Plesca. The network helps show where Dragos Plesca may publish in the future.
Co-authors
The 25 scholars most cited alongside Dragos Plesca, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 329 | |
| 2 | 2008 | 173 | |
| 3 | 2018 | 62 | |
| 4 | 2007 | 59 | |
| 5 | 2008 | 42 | |
| 6 | 2007 | 33 | |
| 7 | 2019 | 29 | |
| 8 | 2007 | 29 | |
| 9 | 2018 | 22 | |
| 10 | 2008 | 17 | |
| 11 | 2013 | 10 | |
| 12 | 2018 | 5 | |
| 13 | 2020 | 3 | |
| 14 | 2017 | 2 | |
| 15 | 2016 | 2 | |
| 16 | 2016 | 1 | |
| 17 | 2018 | 1 | |
| 18 | Hematopoietic cell transplantation in chronic myeloid leukemia in the age of tyrosine kinase inhibitors. | 2015 | 1 |
About Dragos Plesca
Dragos Plesca is a scholar working on Oncology, Molecular Biology, Hematology, Infectious Diseases and Genetics, having authored 18 papers that have together received 820 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (5 papers), Cancer-related Molecular Pathways (5 papers), DNA Repair Mechanisms (4 papers), Neutropenia and Cancer Infections (3 papers), Antifungal resistance and susceptibility (2 papers), Microtubule and mitosis dynamics (2 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Oncology (194 citations), Cancer Research (91 citations), Transplantation (14 citations), Molecular Biology (384 citations) and Pharmacology (47 citations). Dragos Plesca has collaborated with scholars based in United States and Australia. Frequent co-authors include Alexandru Almasan, Suparna Mazumder, Michael Kinter, Zahra Mahmoudjafari, Kathryn A. Culos, Katie S. Gatwood, Meredith E. Crosby, Damodar Gupta, Justin Arnall and Edward A. Copelan. Their work appears in journals such as Blood, Cell Cycle, Biology of Blood and Marrow Transplantation, Clinical Pharmacology & Therapeutics and American Journal of Health-System Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.